Literature DB >> 24990882

Recipient NK cell inactivation and intestinal barrier loss are required for MHC-matched graft-versus-host disease.

Sam C Nalle1, H Aimee Kwak1, Karen L Edelblum1, Nora E Joseph1, Gurminder Singh1, Galina F Khramtsova1, Eric D Mortenson1, Peter A Savage2, Jerrold R Turner2.   

Abstract

Previous studies have shown a correlation between pretransplant conditioning intensity, intestinal barrier loss, and graft-versus-host disease (GVHD) severity. However, because irradiation and other forms of pretransplant conditioning have pleiotropic effects, the precise role of intestinal barrier loss in GVHD pathogenesis remains unclear. We developed GVHD models that allowed us to isolate the specific contributions of distinct pretransplant variables. Intestinal damage was required for the induction of minor mismatch [major histocompatibility complex (MHC)-matched] GVHD, but was not necessary for major mismatch GVHD, demonstrating fundamental pathogenic distinctions between these forms of disease. Moreover, recipient natural killer (NK) cells prevented minor mismatch GVHD by limiting expansion and target organ infiltration of alloreactive T cells via a perforin-dependent mechanism, revealing an immunoregulatory function of MHC-matched recipient NK cells in GVHD. Minor mismatch GVHD required MyD88-mediated Toll-like receptor 4 (TLR4) signaling on donor cells, and intestinal damage could be bypassed by parenteral lipopolysaccharide (LPS) administration, indicating a critical role for the influx of bacterial components triggered by intestinal barrier loss. In all, the data demonstrate that pretransplant conditioning plays a dual role in promoting minor mismatch GVHD by both depleting recipient NK cells and inducing intestinal barrier loss.
Copyright © 2014, American Association for the Advancement of Science.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24990882      PMCID: PMC4161673          DOI: 10.1126/scitranslmed.3008941

Source DB:  PubMed          Journal:  Sci Transl Med        ISSN: 1946-6234            Impact factor:   17.956


  50 in total

1.  Gastro-intestinal toxicity related to bone marrow transplantation: disruption of the intestinal barrier precedes clinical findings.

Authors:  J E Johansson; T Ekman
Journal:  Bone Marrow Transplant       Date:  1997-05       Impact factor: 5.483

2.  Prevention of infection and graft-versus-host disease by suppression of intestinal microflora in children treated with allogeneic bone marrow transplantation.

Authors:  J M Vossen; P J Heidt; H van den Berg; E J Gerritsen; J Hermans; L J Dooren
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1990-01       Impact factor: 3.267

3.  Total body irradiation and acute graft-versus-host disease: the role of gastrointestinal damage and inflammatory cytokines.

Authors:  G R Hill; J M Crawford; K R Cooke; Y S Brinson; L Pan; J L Ferrara
Journal:  Blood       Date:  1997-10-15       Impact factor: 22.113

4.  Regimen-related toxicity in patients undergoing bone marrow transplantation.

Authors:  S I Bearman; F R Appelbaum; C D Buckner; F B Petersen; L D Fisher; R A Clift; E D Thomas
Journal:  J Clin Oncol       Date:  1988-10       Impact factor: 44.544

5.  Activated, but not resting, T cells can be recognized and killed by syngeneic NK cells.

Authors:  Brian A Rabinovich; Jennifer Li; John Shannon; Rose Hurren; Jan Chalupny; David Cosman; Richard G Miller
Journal:  J Immunol       Date:  2003-04-01       Impact factor: 5.422

6.  Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway.

Authors:  Masahiro Yamamoto; Shintaro Sato; Hiroaki Hemmi; Katsuaki Hoshino; Tsuneyasu Kaisho; Hideki Sanjo; Osamu Takeuchi; Masanaka Sugiyama; Masaru Okabe; Kiyoshi Takeda; Shizuo Akira
Journal:  Science       Date:  2003-07-10       Impact factor: 47.728

Review 7.  Experimental and clinical gnotobiotics: influence of the microflora on graft-versus-host disease after allogeneic bone marrow transplantation.

Authors:  P J Heidt; J M Vossen
Journal:  J Med       Date:  1992

8.  A role for NK cells as regulators of CD4+ T cells in a transfer model of colitis.

Authors:  M M Fort; M W Leach; D M Rennick
Journal:  J Immunol       Date:  1998-10-01       Impact factor: 5.422

9.  Natural suppressor-like cells in local graft-vs-host disease.

Authors:  G J Prud'homme; D C Bocarro
Journal:  Cell Immunol       Date:  1989-02       Impact factor: 4.868

10.  Macrophage priming and lipopolysaccharide-triggered release of tumor necrosis factor alpha during graft-versus-host disease.

Authors:  F P Nestel; K S Price; T A Seemayer; W S Lapp
Journal:  J Exp Med       Date:  1992-02-01       Impact factor: 14.307

View more
  20 in total

Review 1.  The mucosal barrier at a glance.

Authors:  Marion M France; Jerrold R Turner
Journal:  J Cell Sci       Date:  2017-01-06       Impact factor: 5.285

Review 2.  The intestinal epithelial barrier: a therapeutic target?

Authors:  Matthew A Odenwald; Jerrold R Turner
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2016-11-16       Impact factor: 46.802

Review 3.  Intestinal microbiota-related effects on graft-versus-host disease.

Authors:  Yusuke Shono; Melissa D Docampo; Jonathan U Peled; Suelen M Perobelli; Robert R Jenq
Journal:  Int J Hematol       Date:  2015-03-27       Impact factor: 2.490

4.  T-bet Promotes Acute Graft-versus-Host Disease by Regulating Recipient Hematopoietic Cells in Mice.

Authors:  Jianing Fu; Yongxia Wu; Hung Nguyen; Jessica Heinrichs; Steven Schutt; Yuejun Liu; Chen Liu; Junfei Jin; Claudio Anasetti; Xue-Zhong Yu
Journal:  J Immunol       Date:  2016-02-22       Impact factor: 5.422

Review 5.  Intestinal barrier loss as a critical pathogenic link between inflammatory bowel disease and graft-versus-host disease.

Authors:  S C Nalle; J R Turner
Journal:  Mucosal Immunol       Date:  2015-05-06       Impact factor: 7.313

6.  Myosin light chain kinase knockout improves gut barrier function and confers a survival advantage in polymicrobial sepsis.

Authors:  C Adam Lorentz; Zhe Liang; Mei Meng; Ching-Wen Chen; Benyam P Yoseph; Elise R Breed; Rohit Mittal; Nathan J Klingensmith; Alton B Farris; Eileen M Burd; Michael Koval; Mandy L Ford; Craig M Coopersmith
Journal:  Mol Med       Date:  2017-06-07       Impact factor: 6.354

Review 7.  Challenges and opportunities targeting mechanisms of epithelial injury and recovery in acute intestinal graft-versus-host disease.

Authors:  Suze A Jansen; Edward E S Nieuwenhuis; Alan M Hanash; Caroline A Lindemans
Journal:  Mucosal Immunol       Date:  2022-06-02       Impact factor: 8.701

Review 8.  Pattern Recognition Receptor Signaling and Cytokine Networks in Microbial Defenses and Regulation of Intestinal Barriers: Implications for Inflammatory Bowel Disease.

Authors:  Clara Abraham; Maria T Abreu; Jerrold R Turner
Journal:  Gastroenterology       Date:  2022-02-09       Impact factor: 33.883

9.  Mechanisms of Intestinal Barrier Dysfunction in Sepsis.

Authors:  Benyam P Yoseph; Nathan J Klingensmith; Zhe Liang; Elise R Breed; Eileen M Burd; Rohit Mittal; Jessica A Dominguez; Benjamin Petrie; Mandy L Ford; Craig M Coopersmith
Journal:  Shock       Date:  2016-07       Impact factor: 3.454

10.  Graft-versus-host disease propagation depends on increased intestinal epithelial tight junction permeability.

Authors:  Sam C Nalle; Li Zuo; Ma Lora Drizella M Ong; Gurminder Singh; Alicia M Worthylake; Wangsun Choi; Mario Cabrero Manresa; Anna P Southworth; Karen L Edelblum; Gregory J Baker; Nora E Joseph; Peter A Savage; Jerrold R Turner
Journal:  J Clin Invest       Date:  2019-01-22       Impact factor: 19.456

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.